Rational Use of Haemophilus influenzae Type b Vaccine???

This publication has 10 references indexed in Scilit:

• Antibody persistence after accelerated immunisation against Haemophilus influenzae type b.
  BMJ, 1993
• Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines
  The Lancet, 1992
• Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule.
  Archives of Disease in Childhood, 1992
• American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization of infants and children 2 months of age and older: update.
  1991
• The Efficacy in Navajo Infants of a Conjugate Vaccine Consisting ofHaemophilus influenzaeType b Polysaccharide andNeisseria meningitidisOuter-Membrane Protein Complex
  New England Journal of Medicine, 1991
• The Epidemiology and Prevention of Disease Caused by Haemophilus influenzae Type b
  Epidemiologic Reviews, 1991
• Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61 080 children
  The Pediatric Infectious Disease Journal, 1991
• Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. Recommendations of the immunization practices advisory committee (ACIP).
  1991
• Prevention ofHemophilus influenzaeType B Bacteremic Infections with the Capsular Polysaccharide Vaccine
  New England Journal of Medicine, 1984
• The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae Type b
  The Journal of Infectious Diseases, 1983